Concepedia

Alan Slade

AS

Statistics

Publications

10

Citations

221

H-Index

10

Active since

2007

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Novartis (China)

Alan Slade is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and cell transplantation.

Top concepts

Publications per year

2007–2020

10

Publications

10

Efficacy and safety of SBR759, a new iron-based phosphate binder

Geoffrey A. Block, Stephanie Brillhart, Martha S. Persky et al. · Kidney International · 2010 · 35 citations · Full text

,

Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open‐Label, Randomized Study

Pierre Quartier, Tamás Constantin, Vyacheslav Chasnyk et al. · Arthritis & Rheumatology · 2020 · 35 citations · Full text

The ability of atropine to prevent and reverse the negative chronotropic effect of fingolimod in healthy subjects

John M. Kovarik, Alan Slade, Gilles‐Jacques Rivière et al. · British Journal of Clinical Pharmacology · 2008 · 33 citations · Full text

An iron stable isotope comparison between human erythrocytes and plasma

Friedhelm von Blanckenburg, Marcus Oelze, Dietmar G. Schmid et al. · Metallomics · 2014 · 28 citations · Full text

Ethnic sensitivity study of fingolimod in white and Asian subjects

John M. Kovarik, Alan Slade, Bryan Voss et al. · International Journal of Clinical Pharmacology and Therapeutics · 2007 · 24 citations

1–5 of 10